Name | dicalcium,(5R,5aR,6S,6aR,7S,10aS)-9-[amino(oxido)methylidene]-7-(dimethylamino)-10a-hydroxy-5-methyl-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracene-1,6,12-triolate |
---|---|
Synonyms |
DOXYCYCLINE CALCIUM
Doxycycline calcium (internal use) EINECS 302-088-9 Vibramycin calcium 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,calcium salt (1:2),(4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha)) Doxycycline calcium [USAN] Doxycycline calcium [USAN:USP] C22H24N2O8.2Ca |
Description | Doxycycline calcium, an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor[1]. Doxycycline calcium shows antibacterial activity and anti-cancer cell proliferation activity[1][2][3][4][5]. |
---|---|
Related Catalog | |
In Vitro | Doxycycline calcium (0.01-10 µg/mL, 4 d) affects growth of glioma cells only under high concentrations[2]. Doxycycline calcium (0.01-10 µg/mL, 24 h) decreases MT-CO1 protein content with concentrations of 1 µg/mL and higher in SVG cells[2]. Doxycycline calcium (100 ng/mL, 1 µg/mL; 24 h) reduces proliferation of human cell lines[4]. Doxycycline calcium (0-250 μM, 72 h) inhibits cell viability of breast cancer cells [5]. Cell Viability Assay[2] Cell Line: LNT-229, G55, and U343 glioma cells Concentration: 0.01, 0.1, 1 or 10 µg/mL Incubation Time: 4 days Result: Affected growth of glioma cells only under high concentration (10 µg/mL). Cell Viability Assay[2] Cell Line: SVG cells Concentration: 0.01, 0.1, 1 or 10 µg/mL Incubation Time: 24 hours Result: Decreaseed MT-CO1 protein content with concentrations of 1 µg/mL and higher. Cell Proliferation Assay[4] Cell Line: MCF 12A, 293T cells Concentration: 100 ng/mL, 1 µg/mL Incubation Time: 96 hours Result: Caused reduced proliferation of MCF 12A and 293T cells at 1 µg/mL. Cell Viability Assay[5] Cell Line: MCF-7, MDA-MB-468 cells Concentration: 0-250 μM Incubation Time: 72 hours Result: Inhibited breast cancer cells in a dose-dependent manner with IC50 values for MCF-7 and MDA-MB-468 of 11.39 μM and 7.13 μM respectively. |
In Vivo | Doxycycline calcium (oral gavage; 200 or 800 mg/kg; once daily; 3 months) reduces MMP-9 activity in untreated HT mice in a dose-dependent manner[3]. Animal Model: 6-month-old female Heterozygous Col3a1-deficient (HT) mice[3] Dosage: 200 or 800 mg/kg Administration: Oral gavage; 200 or 800 mg/kg; once daily; 3 months Result: Reduced MMP-9 activity in a dose-dependent manner. |
References |
Boiling Point | 685.2ºC at 760mmHg |
---|---|
Molecular Formula | C22H20Ca2N2O8 |
Molecular Weight | 520.55900 |
Flash Point | 368.2ºC |
Exact Mass | 520.04700 |
PSA | 137.62000 |
LogP | 0.82460 |